197 related articles for article (PubMed ID: 27131869)
1. Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus.
Kanwal F; Kramer JR; El-Serag HB; Frayne S; Clark J; Cao Y; Taylor T; Smith D; White D; Asch SM
Clin Infect Dis; 2016 Aug; 63(3):291-9. PubMed ID: 27131869
[TBL] [Abstract][Full Text] [Related]
2. Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016.
Jung J; Du P; Feldman R; Kong L; Riley T
J Manag Care Spec Pharm; 2019 Nov; 25(11):1236-1242. PubMed ID: 31663464
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.
Marcus JL; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Lam JO; Pauly MP; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ
Public Health Rep; 2018; 133(4):452-460. PubMed ID: 29750893
[TBL] [Abstract][Full Text] [Related]
4. Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort.
Benhammou JN; Dong TS; May FP; Kawamoto J; Dixit R; Jackson S; Dixit V; Bhattacharya D; Han SB; Pisegna JR
Pharmacol Res Perspect; 2018 Apr; 6(2):e00379. PubMed ID: 29484189
[TBL] [Abstract][Full Text] [Related]
5. Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.
Njei B; Esserman D; Krishnan S; Ohl M; Tate JP; Hauser RG; Taddei T; Lim J; Justice AC
Med Care; 2019 Apr; 57(4):279-285. PubMed ID: 30807449
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial Obstacles to Hepatitis C Treatment Initiation Among Patients in Care: A Hitch in the Cascade of Cure.
Spradling PR; Zhong Y; Moorman AC; Rupp LB; Lu M; Gordon SC; Teshale EH; Schmidt MA; Daida YG; Boscarino JA;
Hepatol Commun; 2021 Mar; 5(3):400-411. PubMed ID: 33681675
[TBL] [Abstract][Full Text] [Related]
7. Short article: Alcohol and substance use, race, and insurance status predict nontreatment for hepatitis C virus in the era of direct acting antivirals: a retrospective study in a large urban tertiary center.
Sims OT; Guo Y; Shoreibah MG; Venkata K; Fitzmorris P; Kommineni V; Romano J; Massoud OI
Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1219-1222. PubMed ID: 28857899
[TBL] [Abstract][Full Text] [Related]
8. Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.
Spradling PR; Xing J; Rupp LB; Moorman AC; Gordon SC; Lu M; Teshale EH; Boscarino JA; Schmidt MA; Daida YG; Holmberg SD;
J Clin Gastroenterol; 2018 Aug; 52(7):641-647. PubMed ID: 28590325
[TBL] [Abstract][Full Text] [Related]
9. Barriers to hepatitis C treatment in the era of direct-acting anti-viral agents.
Lin M; Kramer J; White D; Cao Y; Tavakoli-Tabasi S; Madu S; Smith D; Asch SM; El-Serag HB; Kanwal F
Aliment Pharmacol Ther; 2017 Nov; 46(10):992-1000. PubMed ID: 28949020
[TBL] [Abstract][Full Text] [Related]
10. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era.
Shaikh A; Goli K; Lee TH; Rich NE; Benhammou JN; Keeling S; Kim D; Ahmed A; Goss J; Rana A; Singal AG; Kanwal F; Cholankeril G
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2288-2297.e4. PubMed ID: 36521738
[TBL] [Abstract][Full Text] [Related]
11. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Treatment Rate of Patients With Hepatitis C Virus Infection in the Direct-Acting Antiviral Era and During the COVID-19 Pandemic in the United States.
Nguyen VH; Kam L; Yeo YH; Huang DQ; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2022 Dec; 5(12):e2245424. PubMed ID: 36477481
[TBL] [Abstract][Full Text] [Related]
13. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?
Du P; Wang X; Kong L; Jung J
Telemed J E Health; 2021 May; 27(5):488-494. PubMed ID: 32882154
[No Abstract] [Full Text] [Related]
14. Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
Lam JO; Hurley LB; Chamberland S; Champsi JH; Gittleman LC; Korn DG; Lai JB; Quesenberry CP; Ready J; Saxena V; Seo SI; Witt DJ; Silverberg MJ; Marcus JL
Int J STD AIDS; 2019 Jun; 30(7):689-695. PubMed ID: 31046611
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Pharmacy-Led Hepatitis C Direct-Acting Antiviral Utilization Management at a Veterans Affairs Medical Center.
Yang S; Britt RB; Hashem MG; Brown JN
J Manag Care Spec Pharm; 2017 Mar; 23(3):364-369. PubMed ID: 28230455
[TBL] [Abstract][Full Text] [Related]
16. Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.
Haque LY; Fiellin DA; Tate JP; Esserman D; Bhattacharya D; Butt AA; Crystal S; Edelman EJ; Gordon AJ; Lim JK; Tetrault JM; Williams EC; Bryant K; Cartwright EJ; Rentsch CT; Justice AC; Lo Re V; McGinnis KA
JAMA Netw Open; 2022 Dec; 5(12):e2246604. PubMed ID: 36515952
[TBL] [Abstract][Full Text] [Related]
17. The association between race/ethnicity and the effectiveness of direct antiviral agents for hepatitis C virus infection.
Su F; Green PK; Berry K; Ioannou GN
Hepatology; 2017 Feb; 65(2):426-438. PubMed ID: 27775854
[TBL] [Abstract][Full Text] [Related]
18. Association of Direct-Acting Antiviral Treatment With Mortality Among Medicare Beneficiaries With Hepatitis C.
Kalidindi Y; Jung J; Feldman R; Riley T
JAMA Netw Open; 2020 Jul; 3(7):e2011055. PubMed ID: 32692371
[TBL] [Abstract][Full Text] [Related]
19. Barriers to hepatitis C direct-acting antiviral therapy among HIV/hepatitis C virus-coinfected persons.
Jatt LP; Gandhi MM; Guo R; Sukhija-Cohen A; Bhattacharya D; Tseng CH; Chew KW
J Gastroenterol Hepatol; 2021 Apr; 36(4):1095-1102. PubMed ID: 32840904
[TBL] [Abstract][Full Text] [Related]
20. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans.
Beck KR; Kim NJ; Khalili M
Ann Hepatol; 2018; 17(3):413-418. PubMed ID: 29735789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
